Posted on 14 April 2015
Tags: big pharma, J&J, Janssen, partnering
Ichor Medical Systems has entered into a product development collaboration and worldwide license agreement with Janssen Pharmaceuticals Read the full story
Posted on 23 March 2015
Tags: big pharma, J&J, Janssen, M&A
Janssen Pharmaceuticals has acquired XO1 Limited Read the full story
Posted on 03 March 2015
Tags: asset purchase, big pharma, J&J
Big pharma giant Johnson & Johnson has found a buyer for its Cordis unit, a manufacturer of cardiology and endovascular devices, which it put on the market in August 2014 . Read the full story
Posted on 12 February 2015
Tags: big pharma, Genzyme, J&J, partnering
Voyager Therapeutics and Genzyme announced a major strategic collaboration to discover, develop and commercialize novel gene therapies for severe CNS disorders Read the full story
Posted on 16 January 2015
Tags: big pharma, J&J, partnering
Depomed has entered into a definitive agreement to acquire the U.S. rights to the NUCYNTA franchise from Janssen Pharmaceuticals for $1.05 billion Read the full story
Posted on 14 January 2015
Tags: big pharma, J&J, Janssen biotech, partnering
Vedanta Biosciences announced a license agreement with Janssen Biotech, for Vedanta's lead microbiome pharmaceutical candidate (VE202) Read the full story
Posted on 13 January 2015
Tags: big pharma, J&J, Janssen, licensing, partnering
AC Immune has entered into a worldwide exclusive license agreement and research collaboration with Janssen Pharmaceuticals Read the full story
Posted on 07 January 2015
Tags: big pharma, biotech, J&J, Janssen biotech, pharma
Vectura has entered into a global development and licence agreement with Janssen Biotech for the exclusive development of novel anti-inflammatory therapies for the treatment of asthma/COPD Read the full story
Posted on 06 January 2015
Tags: big pharma, J&J, Janssen biotech, partnering
Isis Pharmaceuticals has entered into a global collaboration with Janssen Biotech to discover and develop antisense drugs to treat autoimmune disorders of the gastrointestinal (GI) tract Read the full story
Posted on 29 December 2014
Tags: J&J, Janssen, licensing, partnering
EB Pharma has executed an agreement with Janssen Pharmaceutica for an exclusive license, to tipifarnib in the field of virology and a related, clinical stage back-up compound Read the full story